Showing results (81-90 of 354) with videos related to
Sort By:
Pageof 36
Transplantation Proceedings|March 1, 2006
Individualization of immunosuppressive therapy. II. Sirolimus as a less nephrotoxic alternative to calcineurin inhibitorsW Lisik, B D KahanClinical Chemistry|November 1, 1991
Abbreviated kinetic profiles in area-under-the-curve monitoring of cyclosporine therapyJ Grevel, B D KahanTransplantation Proceedings|December 17, 2011
Better actual 10-year renal transplant outcomes of 80% reduced cyclosporine exposure with sirolimus base therapy compared with full cyclosporine exposure without or with concomittant sirolimus treatmentJ Pliszczynski, B D KahanTherapeutic Drug Monitoring|March 1, 1991
Area under the curve monitoring of cyclosporine therapy: the early posttransplant periodJ Grevel, B D KahanClinical Pharmacology and Therapeutics|August 1, 1993
Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantationA Lindholm, B D KahanPediatric Nephrology (Berlin, Germany)|October 1, 1993
New immunosuppressive agents for pediatric transplantationM Ferraresso, B D KahanTransplantation Proceedings|January 3, 2006
Individualization of immunosuppressive therapy: I. Sirolimus improves outcomes in African-American renal transplant recipientsH Podder, B D KahanTransplantation|October 1, 1985
The immunosuppressive action of suppressor cells from antigen-cyclosporine-treated hosts on renal allograft survivalN Yoshimura, B D KahanTransplantation|December 1, 1986
The requirement for the renal transplant to induce allograft unresponsiveness by the combination of extracted histocompatibility antigen and cyclosporineN Yoshimura, B D KahanTransplantation|February 1, 1985
Nature of the suppressor cells mediating prolonged graft survival after administration of extracted histocompatibility antigen and cyclosporineN Yoshimura, B D KahanPageof 36